Widespread intronic polyadenylation inactivates tumour suppressor genes in leukaemia
Top Cited Papers
- 27 August 2018
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature
- Vol. 561 (7721), 127-131
- https://doi.org/10.1038/s41586-018-0465-8
Abstract
DNA mutations are known cancer drivers. Here we investigated whether mRNA events that are upregulated in cancer can functionally mimic the outcome of genetic alterations. RNA sequencing or 3′-end sequencing techniques were applied to normal and malignant B cells from 59 patients with chronic lymphocytic leukaemia (CLL)1,2,3. We discovered widespread upregulation of truncated mRNAs and proteins in primary CLL cells that were not generated by genetic alterations but instead occurred by intronic polyadenylation. Truncated mRNAs caused by intronic polyadenylation were recurrent (n = 330) and predominantly affected genes with tumour-suppressive functions. The truncated proteins generated by intronic polyadenylation often lack the tumour-suppressive functions of the corresponding full-length proteins (such as DICER and FOXN3), and several even acted in an oncogenic manner (such as CARD11, MGA and CHST11). In CLL, the inactivation of tumour-suppressor genes by aberrant mRNA processing is substantially more prevalent than the functional loss of such genes through genetic events. We further identified new candidate tumour-suppressor genes that are inactivated by intronic polyadenylation in leukaemia and by truncating DNA mutations in solid tumours4,5. These genes are understudied in cancer, as their overall mutation rates are lower than those of well-known tumour-suppressor genes. Our findings show the need to go beyond genomic analyses in cancer diagnostics, as mRNA events that are silent at the DNA level are widespread contributors to cancer pathogenesis through the inactivation of tumour-suppressor genes.Keywords
This publication has 46 references indexed in Scilit:
- Ubiquitously transcribed genes use alternative polyadenylation to achieve tissue-specific expressionGenes & Development, 2013
- Direct Competition between hnRNP C and U2AF65 Protects the Transcriptome from the Exonization of Alu ElementsCell, 2013
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics DataCancer Discovery, 2012
- A continuum model for tumour suppressionNature, 2011
- Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemiaNature, 2011
- Down-regulation of Chondroitin 4-O-Sulfotransferase-1 by Wnt Signaling Triggers Diffusion of Wnt-3aPublished by Elsevier BV ,2011
- The transcription factors T-bet and GATA-3 control alternative pathways of T-cell differentiation through a shared set of target genesProceedings of the National Academy of Sciences of the United States of America, 2009
- Widespread Shortening of 3′UTRs by Alternative Cleavage and Polyadenylation Activates Oncogenes in Cancer CellsCell, 2009
- Global mapping of c-Myc binding sites and target gene networks in human B cellsProceedings of the National Academy of Sciences of the United States of America, 2006
- Genetics of chronic lymphocytic leukemia: genomic aberrations and VH gene mutation status in pathogenesis and clinical courseLeukemia, 2002